124 related articles for article (PubMed ID: 9259760)
1. Effects of the allosteric modification of hemoglobin on brain oxygen and infarct size in a feline model of stroke.
Watson JC; Doppenberg EM; Bullock MR; Zauner A; Rice MR; Abraham D; Young HF
Stroke; 1997 Aug; 28(8):1624-30. PubMed ID: 9259760
[TBL] [Abstract][Full Text] [Related]
2. The rationale for, and effects of oxygen delivery enhancement to ischemic brain in a feline model of human stroke.
Doppenberg EM; Watson JC; Bullock R; Gerber MJ; Zauner A; Abraham DJ
Ann N Y Acad Sci; 1997 Oct; 825():241-57. PubMed ID: 9369991
[TBL] [Abstract][Full Text] [Related]
3. Effects of RSR13, a synthetic allosteric modifier of hemoglobin, alone and in combination with dizocilpine, on outcome from transient focal cerebral ischemia in the rat.
Sarraf-Yazdi S; Sheng H; Grocott HP; Bart RD; Pearlstein RD; Steffen RP; Warner DS
Brain Res; 1999 May; 826(2):172-80. PubMed ID: 10224294
[TBL] [Abstract][Full Text] [Related]
4. Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats.
Abraham DJ; Wireko FC; Randad RS; Poyart C; Kister J; Bohn B; Liard JF; Kunert MP
Biochemistry; 1992 Sep; 31(38):9141-9. PubMed ID: 1390701
[TBL] [Abstract][Full Text] [Related]
5. Effect of an allosteric modifier of hemoglobin, RSR-4, on oxygen affinity and oxygen saturation of hemoglobin in rabbits.
Uchida K; Reilly MP; Abraham DJ; Asakura T
Jpn J Physiol; 1998 Dec; 48(6):439-44. PubMed ID: 10021497
[TBL] [Abstract][Full Text] [Related]
6. RSR-13, an allosteric effector of hemoglobin, increases systemic and iliac vascular resistance in rats.
Kunert MP; Liard JF; Abraham DJ
Am J Physiol; 1996 Aug; 271(2 Pt 2):H602-13. PubMed ID: 8770102
[TBL] [Abstract][Full Text] [Related]
7. Efficacious experimental stroke treatment with high-dose methylprednisolone.
de Courten-Myers GM; Kleinholz M; Wagner KR; Xi G; Myers RE
Stroke; 1994 Feb; 25(2):487-92; discussion 493. PubMed ID: 8303761
[TBL] [Abstract][Full Text] [Related]
8. Allosteric modification of oxygen delivery by hemoglobin.
Wahr JA; Gerber M; Venitz J; Baliga N
Anesth Analg; 2001 Mar; 92(3):615-20. PubMed ID: 11226087
[TBL] [Abstract][Full Text] [Related]
9. Post-ischemic RSR13 amplifies the effect of dizocilpine on outcome from transient focal cerebral ischemia in the rat.
Mackensen GB; Nellgård B; Sarraf-Yazdi S; Dexter F; Steffen RP; Grocott HP; Warner DS
Brain Res; 2000 Jan; 853(1):15-21. PubMed ID: 10627303
[TBL] [Abstract][Full Text] [Related]
10. High-resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector.
Safo MK; Moure CM; Burnett JC; Joshi GS; Abraham DJ
Protein Sci; 2001 May; 10(5):951-7. PubMed ID: 11316875
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological correction of hypothermic P(50) shift does not alter outcome from focal cerebral ischemia in rats.
Wainwright MS; Sheng H; Sato Y; Mackensen GB; Steffen RP; Pearlstein RD; Warner DS
Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1863-70. PubMed ID: 11959653
[TBL] [Abstract][Full Text] [Related]
12. RSR13, a synthetic modifier of hemoglobin-oxygen affinity, enhances the recovery of stunned myocardium in anesthetized dogs.
Pagel PS; Hettrick DA; Montgomery MW; Kersten JR; Steffen RP; Warltier DC
J Pharmacol Exp Ther; 1998 Apr; 285(1):1-8. PubMed ID: 9535987
[TBL] [Abstract][Full Text] [Related]
13. Low-affinity hemoglobin increases tissue PO2 and decreases arteriolar diameter and flow in the rat cremaster muscle.
Kunert MP; Liard JF; Abraham DJ; Lombard JH
Microvasc Res; 1996 Jul; 52(1):58-68. PubMed ID: 8812756
[TBL] [Abstract][Full Text] [Related]
14. Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation.
Khandelwal SR; Randad RS; Lin PS; Meng H; Pittman RN; Kontos HA; Choi SC; Abraham DJ; Schmidt-Ullrich R
Am J Physiol; 1993 Oct; 265(4 Pt 2):H1450-3. PubMed ID: 8238433
[TBL] [Abstract][Full Text] [Related]
15. The dose-dependent effect of RSR13, a synthetic allosteric modifier of hemoglobin, on physiological parameters and brain tissue oxygenation in rats.
Grinberg OY; Miyake M; Hou H; Steffen RP; Swartz HM
Adv Exp Med Biol; 2003; 530():287-96. PubMed ID: 14562725
[TBL] [Abstract][Full Text] [Related]
16. Modeling of the response of ptO2 in rat brain to changes in physiological parameters.
Grinberg OY; Hou H; Roche MA; Merlis J; Grinberg SA; Khan N; Swartz HM; Dunn JF
Adv Exp Med Biol; 2005; 566():111-8. PubMed ID: 16594142
[TBL] [Abstract][Full Text] [Related]
17. Preservation of canine myocardial high-energy phosphates during low-flow ischemia with modification of hemoglobin-oxygen affinity.
Weiss RG; Mejia MA; Kass DA; DiPaula AF; Becker LC; Gerstenblith G; Chacko VP
J Clin Invest; 1999 Mar; 103(5):739-46. PubMed ID: 10074492
[TBL] [Abstract][Full Text] [Related]
18. Effects of a synthetic allosteric modifier of hemoglobin oxygen affinity on outcome from global cerebral ischemia in the rat.
Grocott HP; Bart RD; Sheng H; Miura Y; Steffen R; Pearlstein RD; Warner DS
Stroke; 1998 Aug; 29(8):1650-5. PubMed ID: 9707208
[TBL] [Abstract][Full Text] [Related]
19. Continuous lidocaine infusion and focal feline cerebral ischemia.
Shokunbi MT; Gelb AW; Wu XM; Miller DJ
Stroke; 1990 Jan; 21(1):107-11. PubMed ID: 2300976
[TBL] [Abstract][Full Text] [Related]
20. Raising P50 increases tissue PO2 in canine skeletal muscle but does not affect critical O2 extraction ratio.
Curtis SE; Walker TA; Bradley WE; Cain SM
J Appl Physiol (1985); 1997 Nov; 83(5):1681-9. PubMed ID: 9375339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
